Osteoclast‐derived Autotaxin, a Distinguishing Factor for Inflammatory Bone Loss

Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.41005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Myostatin - A New Player in Inflammatory Bone Loss

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

Bone-Derived Neurotrophic Factor (BDNF)

Science-Business eXchange
2010English

Loss of CBL-B Increases Osteoclast Bone-Resorbing Activity and Induces Osteopenia

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2009English

Dynein Light Chain LC8 Inhibits Osteoclast Differentiation and Prevents Bone Loss in Mice

Journal of Immunology
AllergyImmunology
2013English

Osteoimmunology of Bone Loss in Inflammatory Rheumatic Diseases

Frontiers in Immunology
AllergyImmunology
2019English

Bone Is Not Essential for Osteoclast Activation

PLoS ONE
Multidisciplinary
2010English

Scanning Electron Microscopic Observation of Bone Marrow-Derived Osteoclast-Like Cells Resorbing Coral.

Japanese Journal of Oral Biology
1997English

Fangchinoline Protects Against Bone Loss in OVX Mice via Inhibiting Osteoclast Formation, Bone Resorption and RANKL-induced Signaling

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2020English

Whole Body Vibration Reduces Inflammatory Bone Loss in a Lipopolysaccharide Murine Model

Journal of Dental Research
Dentistry
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy